Premium
P2‐178: Neuropathological heterogeneity underlying homogeneous clinicopathological correlation in advanced dementia
Author(s) -
Zea-Sevilla María Ascensión,
Fernández-Blazquez Miguel Angel,
Calero Miguel,
Bermejo-Velasco Pedro,
Rabano Alberto
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.717
Subject(s) - hippocampal sclerosis , pathology , vascular dementia , dementia , neuropathology , medicine , homogeneous , alzheimer's disease , psychology , disease , psychiatry , temporal lobe , physics , epilepsy , thermodynamics
P2-176 ARE CORTICAL SOURCES OFAUDITORY Figure 1. Individual values of the cortical (LORETA) sources of auditory P3a and P3b peak in the Ab-negative and Ab-positive aMCI subjects. For P3a peak, the individual values for Brodmann area (BA) 8, BA 9, BA 10, ODDBALL EVENT-RELATED POTENTIALS AN EARLY DIAGNOSTIC MARKEROFALZHEIMER’S DISEASE? BA 11, BA 44, BA 45, BA 46, and BA 47 are reported. For P3b, the individual values for BA 5, BA7, BA 39, BA 40, BA 22, BA 42, BA 23, and BA 31 are reported. Claudio Babiloni, Claudio Del Percio, Nicola Marzano, Susanna Cordone, Giuseppe Noce, Christina Bagnoli, Paolo Maria Rossini, Andrea Soricelli, Flavio Nobili, David Bartres, Olivier Blin, Pierre Payoux, Regis Bordet, Bernhard W. Muller, Magda Tsolaki, Lucilla Parnetti, Ulrich Hegerl, Tilman Hensch, Juergen Dukart, Alessandro Bartolino, Gianluigi Forloni, Jill Richardson, Giovanni Battista Frisoni, Sapienza University of Rome, Rome, Italy; IRCCS San Raffaele Pisana, Rome, Italy; University of Foggia, Foggia, Italy; IRCCS SDN, Naples, Italy; IRCCS Istituto Centro SanGiovanni di Dio Fatebenefratelli, Brescia, Italy; Catholic University of Rome, Rome, Italy; University of Genoa, Genoa, Italy; Universitat de Barcelona and IDIBAPS, Barcelona, Spain; Mediterranean Institute of Cognitive Neurosciences, Marseille, France; Universit e de Toulouse, Toulouse, France; Lille 2 University, Lille, France; University of Duisburg-Essen, Essen, Germany; Aristotle University of Thessaloniki, Thessaloniki, Greece; University of Perugia, Perugia, Italy; University of Leipzig, Leipzig, Germany; Roche, Basel, Switzerland; IRCCS Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy; Neurosciences Therapeutic Area, U.K., United Kingdom. Contact e-mail: claudio.babiloni@uniroma1.it